UK tests Life-Saving baby screening for devastating muscle disease
NCT ID NCT05481164
Summary
This study tested a new screening program for babies to detect spinal muscular atrophy (SMA), a severe genetic muscle disease, as early as possible. Over 33,500 newborns in the UK were screened using a tiny extra blood spot from their routine newborn test. The goal was to see if this screening is practical, reliable, and accepted by parents, so babies with SMA can be diagnosed and treated before symptoms cause irreversible damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCULAR ATROPHY, SPINAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Buckinghamshire HealthCare Trust
Buckingham, United Kingdom
-
Dorset County Hospital (DCHFT)
Dorchester, DT1 2JY, United Kingdom
-
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes, United Kingdom
-
Princess Anne Hospital
Southampton, United Kingdom
-
Queen Alexandra Hospital
Portsmouth, United Kingdom
-
Royal Berkshire NHS Foundation Trust
Reading, United Kingdom
-
Salisbury District Hospital
Salisbury, United Kingdom
-
St Mary's Maternity Hospital
Poole, United Kingdom
-
University of Oxford UK
Oxford, United Kingdom
Conditions
Explore the condition pages connected to this study.